Your session is about to expire
← Back to Search
G1899 Korean Red Ginseng Extract Powder 120 mg/tablet for Vasodilation
Study Summary
This trial aims to find out if the TP has any effect on blood flow and platelet aggregation, and if it is beneficial for cardiovascular health. It also wants to understand if the TP is safe and
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals above the age of 20 eligible to participate in this ongoing medical study?
"Prospective participants for this study must be within the age range of 20 and 75 years old, with an upper limit on their eligibility."
What is the current number of participants enrolled in this clinical study?
"Indeed, the information found on clinicaltrials.gov confirms that this particular trial is actively seeking participants. The study was first posted on January 1st, 2024 and recently updated on January 31st, 2024. The research team aims to recruit a total of 120 patients from a single designated site."
Are there any available openings for patients to participate in this medical study?
"Indeed, as per clinicaltrials.gov, this study is currently in the recruitment phase. The trial was first posted on January 1st, 2024 and underwent its latest revision on January 31st, 2024."
What are the primary objectives of this scientific study?
"The primary objective of this study, to be evaluated over a period of approximately 12 weeks, is to measure platelet aggregation. Secondary outcomes include assessing blood coagulation through prothrombin time (PT), measuring the change from baseline to 12 weeks in PT for both placebo and test products. Additionally, systolic blood pressure (SBP) at rest will be assessed by comparing the change from baseline to 6 weeks in SBP levels while seated and supine between placebo and test products. Lastly, changes in heart rate (beats per minute) will also be monitored from baseline throughout the study."
Is it possible for me to enroll as a participant in this clinical trial?
"Applicants who are between the ages of 20 and 75 and have a documented history of cardiovascular disease are eligible for enrollment in this clinical trial. The study aims to accept approximately 120 participants."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger